Notice2026-19538
Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 24, 2026
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Cambridge Isotope Laboratories, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 184 (Thursday, September 24, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 184 (Thursday, September 24, 2026)]
[Notices]
[Page 60655]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-19538]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1771]
Bulk Manufacturer of Controlled Substances Application: Cambridge
Isotope Laboratories, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cambridge Isotope Laboratories, Inc. has applied to be
registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to Supplementary Information listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
December 23, 2026. Such persons may also file a written request for a
hearing on the application on or before November 23, 2026.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 19, 2026, Cambridge Isotope Laboratories,
Inc., 50 Frontage Road, Andover, Massachusetts 01810-5413, applied to
be registered as a bulk manufacturer of the following basic class(es)
of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Tetrahydro-cannabinols................. 7370 I
------------------------------------------------------------------------
The company plans to synthetically bulk manufacture the controlled
substance Tetrahydrocannabinols to produce analytical standards for
distribution to its customers. No other activity for this drug code is
authorized for this registration.
Justin Wood,
Deputy Assistant Administrator.
[FR Doc. 2026-19538 Filed 9-23-26; 8:45 am]
BILLING CODE 4410-09-P
</pre></body>
</html>Indexed from Federal Register on September 24, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.